About Us President's Letter Mission Statement Our Origins Goals & Standards Board of Directors Curriculum Committee Continuing Education Committee Privacy Policy Complete List of Courses Open Enrollment Courses Corporate Educational Programs Distance Education Courses Webinars   NEW Pharmaceutical Medicine Certificate Programs Career Planning Our Faculty Become PERI Faculty     About Us    |    Opportunities    |    Mailing List    |    Contact Us    |    Search    |    Home   Continuing Education Committee Dennis W. Adair, PharmD, PhD Pharmaceutical Development Consultant John F. Beary, III, MD Medical Director Arthritis Research Worldwide Clinical Development Procter & Gamble Pharmaceuticals Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP Professor and Chairman Department of Pharmacotherapy College of Pharmacy Washington State University Gene L. Colice, MD Director Department of Pulmonary Critical Care and Respiratory Service Washington Hospital Center Carl J. Eastwood, Jr. Section Head Clinical Operations Procter & Gamble Pharmaceuticals Health Care Research Center Anthony W. Fox, MD, PhD, BSC, MBBS President Drug Development EBD Group Elinor Miller, MD, FAAP, FACC, FACP, MFP Senior Medical Director U.S. Drug Development AstraZeneca Pharmaceuticals L.P. Anthony J. Piraino, MD, PhD Director Clinical Pharmacology and Clinical Research Respiratory AstraZeneca, LP Cheryl J. Priest, RN Independant Clinical Development Training and Quality Process Consultant   Peter H. Slugg, MD, FACP Director Clinical Pharmacology Bristol-Myers Squibb Pharmaceutical Research Institute Hugh H. Tilson, MD, DrPH Senior Advisor to the Dean Clinical Professor of Epidemiology and Health Policy School of Public Health University of North Carolina